Nightingale Announces Plans to Launch its Leading ASP EMR, Nightingale On
Demand, for the Apple® iPad(TM)

MARKHAM, ON, Dec. 9 /CNW/ - Nightingale Informatix Corporation (TSX-V: NGH) ("Nightingale" or the "Company"), an application service provider (ASP) of Electronic Medical Record (EMR) software and related services today announces plans to launch  its leading, internet-based EMR and practice management solution, Nightingale On Demand, for use on the Apple^® iPad™. 

"We are seeing increased use of the iPad™ by physicians and in hospitals and clinics alike - so making Nightingale On Demand available for those who use the device was a natural next step," said Sam Chebib, President and CEO of Nightingale. "Nightingale is committed to product innovation that makes EMR implementation easier for physicians, and helps them further enhance the delivery of patient care. Professionals using the iPad™ will be able to document and view patient information in a way they are most comfortable with. We are continuing to deliver on the Company's Promise to provide physicians with platform choices that work best for them."

Nightingale is leading the Canadian EMR market as one of the first companies with plans to launch an iPad™-enabled solution. Nightingale On Demand's internet-based platform makes it easier for the Company to deploy the solution across various web-enabled devices like the iPad™, in comparison to local client server-based EMRs. 

Physicians and healthcare providers will have the comfort of knowing that all patient data entered while using the iPad™ is stored directly to the same secure servers Nightingale uses for its existing ASP EMR, and that no patient data will remain on the iPad™ device.

"For several years now, I have been using the Nightingale On Demand EMR on various Apple™ devices," said Dr. David M. Kaplan, Assistant Professor of Family & Community Medicine at the University of Toronto. "I'm very pleased that Nightingale will soon be supporting the iPad™ natively because I see more and more physicians using the device. I think using Nightingale's EMR on an iPad™ will be particularly useful for making hospital rounds, offsite patient management and homecare, as well as visits with palliative or nursing home patients. Many day-to-day tasks, like viewing lab results and sending messages and action items to team and staff members will also be easy to do on the iPad™."

Physicians and healthcare providers using Nightingale On Demand on the iPad™ will have access to features available through the existing version of the EMR, including documentation of patient encounters, prescription writing, lab orders and results as well as scheduling and billing of patient visits.

Nightingale will make the iPad™ version of Nightingale On Demand commercially available in March 2011.

About Nightingale Informatix Corporation

Nightingale is one of the fastest growing healthcare service and software companies in North America. It is recognized as an industry leader in web based (ASP) clinician and community based electronic medical records (EMR) serving the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Coupled with integrated practice management, transcription and revenue cycle management, Nightingale's comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base.  Nightingale - Healthcare connected.  www.nightingalemd.com

Forward Looking Statement

This press release contains "forward-looking statements" respecting the issuance and cancellation of securities of the Company within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully integrate its acquisitions and any liabilities arising as a result of such acquisitions, access to capital and agreements with its Lenders; the existence of present and possible future government regulation; access to debt or equity financing and agreements with its Lenders; the significant and increasing competition that exists in the medical software industry; the early stage of Nightingale's business; and therefore it is subject to the risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding.  All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Although management believes the assumptions used to make such statements are reasonable at this time, our assumptions may not to be as anticipated, estimated or intended. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding Nightingale's continued ability to fund its business, rates of customer defaults, relationships with, and payments to, lenders, demand for Nightingale's products, as well as Nightingale's operating cost structure.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Media Inquiries
Michael McMillan
Veritas Communications
T 416.955.4583
[email protected]

Investor Inquiries
Kristen Dickson, M.Sc.
Equicom, a TMX Group Company
Tel: [phone] ext. 273
[email protected]